228,253 Personalis, Inc. $PSNL Shares Sold by Howland Capital Management LLC

Key Points

• Howland Capital Management cut its Personalis stake by 41.1%, selling 228,253 shares and retaining 327,388 shares valued at approximately $5.33 million.
• Other major institutions, including Merck, BlackRock, Bank of America and AIGH Capital Management, recently established positions; institutional investors now own 61.91% of Personalis.
• Personalis shares opened at $15.82, while analysts maintain an average “Hold” rating with a $14.54 price target. The company missed quarterly EPS estimates despite revenue exceeding expectations.

Howland Capital Management LLC decreased its holdings in Personalis, Inc. (NASDAQ:PSNL - Free Report) by 41.1% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 327,388 shares of the company's stock after selling 228,253 shares during the period. Howland Capital Management LLC owned approximately 0.31% of Personalis worth $5,330,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of PSNL. Merck & Co. Inc. acquired a new stake in Personalis in the second quarter valued at about $188,202,236. BlackRock Inc. bought a new position in Personalis in the second quarter valued at about $94,905,000. Bank of America Corp DE bought a new position in Personalis in the second quarter valued at about $24,395,000. AIGH Capital Management LLC bought a new position in Personalis in the second quarter valued at about $22,981,000. Finally, Bank of New York Mellon Corp acquired a new position in Personalis during the second quarter worth about $2,533,000. Institutional investors and hedge funds own 61.91% of the company's stock.

Personalis Stock Down 0.5%

NASDAQ PSNL opened at $15.82 on Friday. Personalis, Inc. has a twelve month low of $4.95 and a twelve month high of $18.89. The company has a market cap of $1.66 billion, a price-to-earnings ratio of -14.51 and a beta of 2.32. The business's fifty day moving average is $16.26 and its 200 day moving average is $12.32.

Personalis (NASDAQ:PSNL - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported ($0.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.04). Personalis had a negative return on equity of 46.47% and a negative net margin of 153.84%. The firm had revenue of $22.36 million for the quarter, compared to the consensus estimate of $16.69 million. On average, research analysts anticipate that Personalis, Inc. will post -1.07 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Zacks Research raised shares of Personalis from a "strong sell" rating to a "hold" rating in a report on Monday, September 7th. Weiss Ratings restated a "sell (d-)" rating on shares of Personalis in a research note on Thursday, October 15th. Needham & Company LLC lowered shares of Personalis from a "buy" rating to a "hold" rating in a report on Monday, July 20th. Craig Hallum cut shares of Personalis from a "buy" rating to a "hold" rating and set a $16.25 price objective for the company. in a research report on Monday, August 24th. Finally, Lake Street Capital cut shares of Personalis from a "buy" rating to a "hold" rating and set a $16.25 price objective for the company. in a research report on Monday, July 20th. Three research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $14.54.

Insider Buying and Selling

In related news, SVP Stephen Moore sold 2,068 shares of the firm's stock in a transaction on Friday, September 18th. The stock was sold at an average price of $16.22, for a total transaction of $33,542.96. Following the completion of the transaction, the senior vice president directly owned 90,257 shares of the company's stock, valued at $1,463,968.54. This trade represents a 2.24% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Aaron Tachibana sold 2,931 shares of Personalis stock in a transaction dated Friday, September 18th. The stock was sold at an average price of $16.22, for a total value of $47,540.82. Following the transaction, the chief financial officer directly owned 195,902 shares in the company, valued at $3,177,530.44. The trade was a 1.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 16,456 shares of company stock valued at $266,916. Company insiders own 4.20% of the company's stock.

Personalis Company Profile

Personalis, Inc is a genomics company focused on applying advanced sequencing and bioinformatics to cancer research and precision medicine. The company develops tests and data platforms designed to help researchers and clinicians characterize tumors, monitor disease, and support the development of targeted therapies.

Its product portfolio includes the NeXT Platform, which analyzes tumor and normal DNA and RNA to provide a detailed view of cancer biology, as well as products such as NeXT Dx, NeXT Liquid Biopsy, and NeXT Personal.

Want to see what other hedge funds are holding PSNL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Personalis, Inc. (NASDAQ:PSNL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.